Life Sciences eNewsletters
View previous Life Sciences eNewsletters:
March 2010 - View March 2010 eNewsletter
August 2009 - View August 2009 eNewsletter
Subscribe: Register your details to subscribe to this and other sector eNewsletters
Latest News
-
Wales is taking the lead in enabling medical manufacturers design affordable, one-off tailor-made devices to meet the health needs of individual patients.
-
11 Aug 2010Orthos launches bone substituteMed-tech company Orthos has launched a bone substitute after receiving a funding boost to back its skeletal injury product development.
-
A Company developing high-value products in the medical dressings and wound healing fields has open a new base in Tredegar, Blaenau Gwent.
-
Port Talbot engineering company Sorbus has won a £500,000-a-year order to process titanium.
-
A Swansea-based magnetic resonance imaging software company, whose technology is pioneering early diagnosis of cancer, organ fibrosis and other diseases, has received a significant fundraising boost.
-
Companies developing the latest technologies to improve healthcare in Wales – ranging from remote monitoring of patients to accessing medical records from a mobile – are set to benefit from a new innovation centre in Swansea.
-
Bridgend pharmaceuticals company Biotec Services International has expanded its ultra-low temperature storage capacity due to increased international demand.
-
An ‘intelligent’ mattress cover that prevents patients developing pressure ulcers or bed sores - which currently costs the NHS more than £1billion a year - was launched in Wales today.
-
29 Mar 2010BioWales 2010 reflects sector successBioWales 2010 came to a close today with organisers heralding the most successful in the event’s eight year history, reflecting a buoyant bioscience sector, described by First Minister of Wales Carwyn Jones as “exceptionally significant to the country, showing every sign that it is weathering the storm.”
-
24 Feb 2010Major breakthrough in understanding Alzheimer’sAlzheimer’s disease is the most common form of dementia in the elderly. It is a devastating, terminal disease in which the symptoms become more severe and debilitating over time. It is incurable: no treatments to delay or halt progression are currently available, only those that relieve the symptoms. It is likely that a combination of risk factors are responsible for Alzheimer’s, such as age (> 65 years) and diet. Genetic inheritance is one such possible risk factor, and researchers have made a great advance: for the first time in more than 15 years, new genetic links to Alzheimer’s have been established.
Have a question? Need more information?
Our team of Relationship Managers are available to answer your business expansion and International trade questions.
|
